1 / 17

THE EFFICACY AND SAFETY OF SHORT PULSE ERBIUM:YAG LASER IN THE TREATMENT OF ACQUIRED MELANOCYTIC NEVI

THE EFFICACY AND SAFETY OF SHORT PULSE ERBIUM:YAG LASER IN THE TREATMENT OF ACQUIRED MELANOCYTIC NEVI. Mete Baba*, Deniz Seçkin*, Nebil Bal** Başkent University Faculty of Medicine Department of Dermatology* and Pathology** .

ansel
Télécharger la présentation

THE EFFICACY AND SAFETY OF SHORT PULSE ERBIUM:YAG LASER IN THE TREATMENT OF ACQUIRED MELANOCYTIC NEVI

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. THE EFFICACY AND SAFETYOF SHORT PULSE ERBIUM:YAG LASER IN THE TREATMENT OF ACQUIRED MELANOCYTIC NEVI Mete Baba*, Deniz Seçkin*, Nebil Bal** Başkent University Faculty of Medicine Department of Dermatology* and Pathology**

  2. No study evaluating the efficacy and safety of an erbium:YAG laser with its small penetration depth and fewer adverse effects in the treatment of acquired melanocytic nevi.

  3. Objective • To investigate the efficacy and safety of short pulse erbium:YAG laser in the treatment of acquired melanocytic nevi

  4. Patients and Methods • Patient selection and consent • Laser treatment • Follow-up • Biopsy and histopathologic assessment

  5. Inclusion criterias • Benign-appearing melanocytic nevi (clinically and dermatoscopically) • Nonfacial localization • Diameter < 6 mm • Flat or just palpable

  6. Lazer treatment 2940 nm 1 J 5 Hz 300 µs

  7. Follow-up • Wound healing • Infection • Scarring • Pigmentary changes

  8. Biopsy and histopathologic assessment • Biopsy (punch) • Histochemical examination • H&E • Masson-Fontana • Immunohistochemical examination • S-100 • HMB-45

  9. Results • 14 patients (10 women and 4 men; aged, 21-38 years; mean, 32.6 years). • Four to ten pulses of laser irradiation were sufficient for clinical removal of all nevi • Epithelization time was between 7 and 10 days • Redness persisted up to 3 weeks in all cases

  10. Results-Safety • Infection; no • Postinflammatory hyperpigmentation; 2 cases • Hypopigmentation; 3 cases

  11. Results-Efficasy • Completeremoval; clinically; all of the nevi, and histopathologically, 27 of 28 nevi • Nevus cells located in dermis (at a depth of 0,25mm); only one specimen

  12. Findings-Histopathology • Epidermis; normal • Dermis; mild fibrosis ranging between 0.19-0.28 mm (mean, 0.24 mm) • Perivascular lymphocyte and eosinophil infiltration; 7 specimens • Several melanophages; 4 specimens

  13. Discussion-Efficasy The depth of vaporization; 2-4 µm for each 1 J/cm2, 4 to 10 pulses of erbium:YAG laser irradiation at fluencies between 5.2 and 14.4 J/cm2 are sufficient to remove nevus cells in the dermo-epidermal junction and the upper dermis. In 1 nevus in this study, incomplete

  14. Discussion-Safety • Melanin pigment içeriği az olan nevüs hücrelerinde yeterli harabiyetin oluşmaması • Epidermal pigment yoğunluğunun blokaj etkisi nedeni ile lazer ışınlarının daha alt seviyelerdeki nevüs hücrelerine ulaşamaması

  15. Malignant transformation • Laser ? Malignant transformation

  16. Erbium: YAG lazer; safe and effective

More Related